Lumipulse® G β-Amyloid 1-40 CSF
Immunoreaction cartridges for research use with the LUMIPULSE G Analyzer for the quantitative measurement of β-amyloid 1-40 in human cerebrospinal fluid. (CSF)
The Lumipulse G β-Amyloid 1-40 assay is intended to be used in conjunction with Lumipulse G β-Amyloid 1-42 assay to determine the amyloid ratio (β-amyloid1-42 / β-amyloid1-40 ratio) in the clinical setting of dementia diagnosis.
This CSF amyloid ratio (β-amyloid1-42 / β-amyloid1-40 ratio) is intended to be used as an aid for diagnosis in patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD) and other causes of cognitive decline.
The CSF amyloid ratio supports the probability of AD pathology only as an adjunct to other diagnostic evaluations.
This product is For Research Use Only (RUO), not for use in diagnostic procedures.
Product # 231685
Product # 231692
Product # 231708